The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Gordon, Kenneth
One or more keywords matched the following items that are connected to Gordon, Kenneth
Item TypeName
Concept Tumor Necrosis Factor-alpha
Concept Receptors, Tumor Necrosis Factor
Academic Article Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.
Academic Article Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.
Academic Article A randomized trial of etanercept as monotherapy for psoriasis.
Academic Article A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
Academic Article Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
Academic Article Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation.
Academic Article Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
Academic Article Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation.
Academic Article The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Academic Article Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article Strategies for treatment with anti-tumor necrosis factor agents in psoriasis: maintaining efficacy and safety for the long haul.
Academic Article Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article Unmet needs in the treatment of psoriasis.
Academic Article A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Academic Article The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
Academic Article In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model.
Academic Article Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.
Academic Article Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.
Academic Article Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Academic Article Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
Academic Article Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Academic Article Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).
Academic Article Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Academic Article Rethinking eligibility creep.
Academic Article Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study.
Academic Article Sequencing of Targeted Therapy in Psoriasis: Does it Matter?
Search Criteria
  • Tumor Necrosis Factor alpha